(Q48726831)

15 February 2018

title

Clinical and polysomnographic features in DQB1*0602 positive and negative narcolepsy patients: results from the modafinil clinical trial. (English)

1 reference

15 February 2018

0 references

1 reference

Hong SC

1

1 reference

15 February 2018

Hayduk R

series ordinal

2

1 reference

15 February 2018

Lim J

series ordinal

3

1 reference

15 February 2018

Mignot E

series ordinal

4

1 reference

15 February 2018

publication date

1 February 2000

1 reference

15 February 2018

number of pages

7

1 reference

inferred from page(s)

published in

Sleep Medicine

1 reference

15 February 2018

volume

1

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

33-39

1 reference

15 February 2018

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

1 reference

7 January 2021

HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

Genetic and familial aspects of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

Autoimmune hypothesis in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

Narcolepsy and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

Prevalence and pathologic associations of sleep paralysis in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

Hypnagogic and hypnopompic hallucinations: pathological phenomena?

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

Stability of cataplexy over several months--information for the design of therapeutic trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

Maintenance of wakefulness test and multiple sleep latency test. Measurement of different abilities in patients with sleep disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

Narcolepsy and disturbed nocturnal sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

Adolescent sleep patterns, circadian timing, and sleepiness at a transition to early school days.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

Pharmacological aspects of human and canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2899%2900007-6

7 January 2021

10.1016/S1389-9457(99)00007-6

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018